Skip to main content
OpenTrials

Clinical trial condition

IgA Nephropathy

Explore clinical trials studying IgA Nephropathy. Study availability and eligibility vary by location and protocol.

85 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

IgA Nephropathy trial results

Active, not recruiting

Atrasentan in Patients With IgA Nephropathy

NCT04573478

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Research Institute Alhambra, California, United States
  • Kidney Disease Medical Group Glendale, California, United States
  • Stanford University Stanford, California, United States
View all 135 locations
View Trial Details
Active, not recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases

NCT04573920

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
Locations
  • Kidney Disease Medical Group Glendale, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • North America Research Institute San Dimas, California, United States
  • Stanford U School Of Medicine Stanford, California, United States
View all 33 locations
View Trial Details
Active, not recruiting

A Study of Zigakibart in Adults With IgA Nephropathy

NCT05852938

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham: The Kirklin Clinic Birmingham, Alabama, United States
  • Nephrology Consultants, LLC Huntsville, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Valiance Clinical Research South Gate, California, United States
View all 200 locations
View Trial Details
Completed

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

NCT05834738

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Nephrology Clinic Birmingham, Alabama, United States
  • Fides Clinical Research Atlanta, Georgia, United States
  • NANI Research Oak Brook, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View all 30 locations
View Trial Details
Completed

TESTING -ON Post-Trial ObservatioNal Cohort Study

NCT05434325

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +17 more
Locations
  • Concord Repatriation General Hospital Concord W., New South Wales, Australia
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 59 locations
View Trial Details
Completed

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

NCT03945318

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Amicis Research Center Northridge, California, United States
  • Colorado Kidney Care, P.C. Denver, Colorado, United States
  • Nephrology Associates of Central Florida Orlando, Florida, United States
  • Elixia Tampa, LLC Tampa, Florida, United States
View all 16 locations
View Trial Details

Related conditions